Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2013
03/19/2013US8399642 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human ribosomal protein L26 (RIBO26)
03/19/2013US8399641 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human tumor suppressing subtransferable candidate 6 (TSSC6)
03/19/2013US8399640 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human SMS3
03/19/2013US8399639 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human achaete-scute homolog 2 (HASH2)
03/19/2013US8399638 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
03/19/2013US8399637 Glutamate receptors; antisense agents; vectors; epiliepsy
03/19/2013US8399631 Compositions and methods for purifying calreticulin
03/19/2013US8399630 Engineered anti-IL-13 antibodies, compositions, methods and uses
03/19/2013US8399628 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof
03/19/2013US8399613 Tumour-associated peptides that bind to MHC molecules
03/19/2013US8399610 HPV vaccine comprising peptides from host cell proteins
03/19/2013US8399427 Reagents, methods and systems to suppress pro-inflammatory cytokines
03/19/2013US8399423 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
03/19/2013US8399421 Treatment for neuropathic pain due to spinal cord injury
03/19/2013US8399384 Focused libraries of genetic packages
03/19/2013US8399257 Transposition of maize Ac/Ds elements in vertebrates
03/19/2013US8399256 Method for introducing gene into cell, and composition for use in the method
03/19/2013US8399248 Methods of using MIR34 as a biomarker for TP53 functional status
03/19/2013US8399246 Baculovirus expression vector and method therewith for generating immunogenicity in a host
03/19/2013US8399242 Production of polyunsaturated fatty acids in oleaginous yeasts
03/19/2013US8399233 Histone deacetylases, and uses related thereto
03/19/2013US8399232 Enzyme associated with equol synthesis
03/19/2013US8399231 Thermus thermophilus nucleic acid polymerases
03/19/2013US8399219 Protease activatable interferon alpha proprotein
03/19/2013US8399217 High density growth of T7 expression strains with auto-induction option
03/19/2013US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same
03/19/2013US8399200 Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers
03/19/2013US8399185 Regulators of NFAT
03/19/2013US8399000 Haemophilus influenzae type IV pili
03/19/2013US8398996 Staphylococcus aureus proteins and nucleic acids
03/19/2013US8398990 Glucan-based vaccines
03/19/2013US8398989 Human cystathionine β-synthase variants and methods of production thereof
03/19/2013US8398986 ADP-ribosylating toxin from listeria monocytogenes
03/19/2013US8398984 Removal promoters and inhibitor for apoptosis cells in vivo
03/19/2013US8398980 Subtypes of humanized antibody against interleuken-6 receptor
03/19/2013US8398968 Adenoviral expression vectors
03/19/2013CA2705716C Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
03/19/2013CA2667814C Waxy wheat starch types having waxy proteins in granule
03/19/2013CA2656259C Process for producing poxviruses and poxvirus compositions
03/19/2013CA2626533C Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue
03/19/2013CA2594728C Maize cyclo1 gene and promoter
03/19/2013CA2556227C Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
03/19/2013CA2551905C Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
03/19/2013CA2536086C Inhibition of dr3 in the treatment of allergic lung inflammation
03/19/2013CA2523879C A coumermycin/novobiocin-regulated gene expression system
03/19/2013CA2491907C Oncolytic virus replicating selectively in tumor cells
03/19/2013CA2483891C Gene targeting using replicating dna molecules
03/19/2013CA2481764C Plants with improved morphogenesis and method of constructing the same
03/19/2013CA2471702C Human monoclonal antibodies against cd30
03/19/2013CA2467455C Method of detection of prostate cancer
03/19/2013CA2452767C Genetic recombinant ecarin and process for preparing the same
03/19/2013CA2452131C Use of untranslated region of osmotin gene to enhance transgene expression in plants
03/19/2013CA2434364C Method for secretory production of glycoprotein having human-type sugar chain using plant cell
03/19/2013CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same
03/19/2013CA2416203C Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants
03/19/2013CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
03/19/2013CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals
03/19/2013CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
03/19/2013CA2195334C Compositions and methods for enhanced tumor cell immunity in vivo
03/19/2013CA1341635C Insect-resistant plants
03/19/2013CA1341634C Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues acertains de ces virus et, le cas echeant, a la vaccination contre le sida
03/14/2013WO2013036892A1 Systems and methods for assessment of biosimilarity
03/14/2013WO2013036879A1 Compositions and methods for treating prostate cancer
03/14/2013WO2013036833A1 Detecting frontotemporal dementia and amyotrophic lateral sclerosis
03/14/2013WO2013036787A2 Cell-free preparation of carbapenems
03/14/2013WO2013036595A1 A stable dw3 allele for sorghum and a molecular marker to facilitate selection
03/14/2013WO2013036332A2 Methods, compositions, and kits for determining hepatitis a virus
03/14/2013WO2013036105A1 Antisense oligonucleotides for the treatment of leber congenital amaurosis
03/14/2013WO2013036101A1 Rubber allergenic proteins and immunoassay derived thereof
03/14/2013WO2013036100A1 A method for regulating plastidial isoprenoid biosynthesis in hevea brasiliensis
03/14/2013WO2013035906A1 Method for preventing and treating salmonella typhimurium infection
03/14/2013WO2013035875A1 Primer set, method for amplifying target nucleic acid sequence using same, and method for detecting mutated nucleic acid using same
03/14/2013WO2013035867A1 Multi-nucleic acid reaction tool, and detection method using same
03/14/2013WO2013035861A1 Method for determining susceptibility to age-related macular degeneration, primer pair, probe, age-related macular degeneration diagnostic kit, therapeutic agent for age-related macular degeneration, and screening method for therapeutic agent for age-related macular degeneration
03/14/2013WO2013035824A1 Cancer stem cell isolation
03/14/2013WO2013035757A1 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
03/14/2013WO2013035678A1 Mutant endoglucanase
03/14/2013WO2013035372A1 Method for producing polyhydroxyalkanoate having long main chain structure
03/14/2013WO2013035209A1 Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor
03/14/2013WO2013035208A1 ANTIBODY AGAINST MUTANT α-ACTININ-4
03/14/2013WO2013035080A1 Penicillium amagasakiense glucose oxidase mutants
03/14/2013WO2013035062A1 A method of preparing biological material
03/14/2013WO2013034747A1 New pepper plants and fruits with improved nutritional value
03/14/2013WO2013034722A1 New parthenocarpic plants with modified expression of auxin response factors and the micrornas inducing said modified expression
03/14/2013WO2013034684A1 Strategies for prevention and/or treatment of diseases based on cd40 silencing
03/14/2013WO2013034653A1 The mirna-212/132 family as a therapeutic target
03/14/2013WO2013034648A1 Increasing the lipid content in microalgae by genetically manipulating a triacylglycerol (tag) lipase
03/14/2013WO2013034579A1 Biosynthetic gene cluster for the production of peptide/protein analogues
03/14/2013WO2013034106A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same
03/14/2013WO2013034097A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
03/14/2013WO2013034069A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013WO2013033961A1 Bivalent vaccine of tumor dna of prame and wt1
03/14/2013WO2013033846A1 Plants having enhanced nitrogen efficiency
03/14/2013WO2013012885A3 Regulatory polynucleotides and uses thereof
03/14/2013WO2013012752A3 Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
03/14/2013WO2013012729A3 Novel plant terminator sequences
03/14/2013WO2013011179A3 Recombinant vectors based on the modified vaccinia ankara (mva) virus, with deletion in the c6l gene, as vaccines against hiv/aids and other diseases
03/14/2013WO2013003630A3 Methods and compositions for enrichment of nucleic acids in mixtures of highly homologous sequences
03/14/2013WO2012178122A3 Phenocopy model of disease
03/14/2013WO2012178046A3 Multivariate diagnostic assays and methods for using same
1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 4023